Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson's Disease.

J Parkinsons Dis · 2024 · PMC11307038 · PMID 38848197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

trending towards significanceno p-value reported

Results: miR-29c-3p was differentially expressed between LRRK2 mutation carriers and sporadic cases, with miR-425-5p trending towards significance.

also in 515 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.